Cite
HARVARD Citation
Zhang, H. et al. (2021). A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects. Annals of medicine. pp. 375-383. [Online].